Equilis® Prequenza Equine Influenza Vaccine (Single Dosage)

MSD Equilis^® Prequenza is a vaccine for the active immunisation against equine influenza.

Equilis^® Prequenza is indicated for the active immunisation of healthy horses and ponies against equine influenza to reduce severity and duration of clinical signs and to reduce the amount and duration of viral shedding after infection.

Directions for use

• Shake well before use.
• Intramuscular injection of 1 dose (1 mℓ) per animal.

Vaccination Schedule

Basic vaccination course
All horses not previously vaccinated should receive 2 vaccinations of 1 dose with a 4-week interval. The basic vaccination course results in immunity to equine influenza lasting at least 5 months. Foals should be vaccinated from the age of 6 months. If vaccination is performed before 6 months of age full protection can be expected after the third vaccination (first revaccination).

Revaccination
The first revaccination (third dose) is given 5 months after the basic vaccination course. The revaccination with Equilis^® Prequenza or Equilis^® Prequenza TE results in immunity to equine influenza for at least 12 months.

The second revaccination is given 12 months after the first revaccination.

The alternate use, at 12-month intervals, of Equilis^® Prequenza is recommended to maintain immunity levels for the influenza component.

Storage

• Store in the dark between 2 °C and 8 °C.
• Do not freeze.
• Avoid prolonged or repetitive exposure to high ambient temperatures following withdrawal from the refrigerator prior to use.
• Protect from direct sunlight.

Warnings

• Vaccinate healthy animals only.
• Avoid intravenous injection.
• A transient swelling may occur after vaccination regressing within 2 days. In some cases, fever may occur after vaccination.
• Do not mix Equilis^® Prequenza with other vaccines, or administer another vaccine shortly before or after vaccination with Equilis^® Prequenza.
• Accidental self-injection may lead to a severe local allergic reaction. Consult a physician immediately and show this package insert to him/her.
• Do not store partially used containers for future use and use the entire contents once opened.
• Dispose of any unused vaccine as well as all empty vaccine containers and vaccination equipment according to local waste disposal regulations.
• A transient swelling may occur after vaccination regressing within 2 days. In some cases, fever may occur after vaccination.
• Shake well before use
• KEEP OUT OF REACH OF CHILDREN, UNINFORMED PERSONS AND ANIMALS.
• Although this vaccine has been extensively tested under a large variety of conditions, failure thereof may ensue as a result of a wide range of reasons. If this is suspected, seek veterinary advice and notify the registration holder.